Study Finds That the Antibiotic Minocycline May Reduce the Likelihood of Transitioning to Definite M

  • Researchers in Canada have published results of a small phase 3 clinical trial showing that minocycline, a relatively inexpensive oral antibiotic commonly used to treat acne, can reduce the likelihood that someone with clinically isolated syndrome (CIS) -- experiencing initial neurological symptoms suggestive of MS -- will go on to develop full-blown multiple sclerosis.
  • Dr. Luanne Metz (University of Calgary) and colleagues across Canada tested minocycline against placebo in 142 people with CIS. After 6 months, those taking twice daily minocycline had a 28% reduced risk of developing definite…

    Favicon of da :

    Prosegui la lettura...
    Traduci l'articolo...

    Sclerosi Multipla News

    Potrebbe interessarti anche

Argomenti correlati